Healthcare -
Biotechnology - NASDAQ - US
$ 33.5
1.73 %
$ 9.57 B
Market Cap
21.61
P/E
EXEL - TOTAL CURRENT LIABILITIES
Total Current Liabilities EXEL - Exelixis, Inc.
394 M
LAST VALUE
8.07%
2 YEAR CAGR
30.18%
5 YEAR CAGR
16.20%
10 YEAR CAGR